Gland Pharma Ltd

Nomura Financial Advisory & Sec. (India) Pvt Ltd

Initial public offer of 43196968 equity shares of face value of Re. 1 each (equity shares) of Gland Pharma Limited (Company or Issuer) for cash at a price of Rs.1500 Per equity share (including a share premium of Rs.1499 per equity share) aggregating Rs.6479.55 crores (The Offer) comprising a fresh issue of 8,333,333 equity shares aggregating up to Rs. 1250 crores on (The fresh issue) and an offer for sale of 34,863,635 equity shares, including 19,368,686 equity shares by Fosun Pharma Industrial Pte. Ltd (promoter selling shareholder) and 10,047,435 equity shares by Gland Celsus Bio Chemicals Private Limited, 3,573,014 equity shares By Empower Discretionary Trust, and 1,874,500 equity shares by Nilay Discretionary Trust (collectively, the other selling shareholders and collectively With the promoter selling shareholder are referred to as the selling shareholders, and such equity shares, the offered shares) aggregating up to Rs. 5229.55 crores (the offer for sale). The offer shall constitute 26.46% of the post-offer paid-up equity share capital of the company.The face value of Equity shares is Re.1 each. The offer price is Rs.1500 per equity share and is 1500 times the face value of the Equity Shares. The Anchor Investor Offer Price is Rs.1500 per Equity Share.

  • Issue

    • Opens On09 Nov 2020
    • Closes On11 Nov 2020
  • Money Payable On

    • Application1500
    • Allotment0
  • Project Cost (Cr.)1250
  • Post Issue Equity Share Capital (Cr.)163.28
  • Issue Price (D)1500

Further Multiples of: 10

Projects

  • Promoted By
    • Listing AtNSE
    • Registrar to the Issue - Link Intime India Pvt Ltd

    Sy No 143-148 150&151 Nr Gandi X Roads D P Pally Dundigal Hyderabad

    Telangana- 500043

    Phone - 91-40-3051 0999

    Fax -

    Email - investors@glandpharma.com

    Website - www.glandpharma.com

    Ready to invest with us?

    Share your Name and Mobile Number with us and get started

    • +91|
    scrollToTop